RxDoctor Payments Data

Kelley White, MD

Internal Medicine · Richmond, VANPI 1720041361

Payments from drug & device makers

$1,414in general payments, 2019–2025

Across 85 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$325
  • Amgen$182
  • Novo Nordisk$127
  • AstraZeneca$111
  • Abbott$103
  • GSK$82
  • plus $484 from 15 others

What the payments were for

  • Food & beverage$1,414100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,414 in reported general payments places this provider in the 80th percentile of 2,724 internal medicine providers in Virginia.

See all internal medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$41,042
Medicare patients
289
Services billed
754

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide23$30,053
TrulicityDulaglutide17$22,227
EliquisApixaban11$18,295
Esomeprazole Magnesium23$4,449
Levothyroxine Sodium306$2,936
SynthroidLevothyroxine Sodium40$2,875
Rosuvastatin Calcium184$2,497
Atorvastatin Calcium253$2,211
Trospium Chloride ErTrospium Chloride13$1,999
Duloxetine Hcl62$1,869
Valsartan91$1,702
Amlodipine Besylate203$1,327
Lisinopril187$1,027
Metronidazole12$992
Simvastatin107$936

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$127$30,05323 claims
Lilly USA, LLCTrulicity$20$22,22717 claims
PfizerEliquis$75$18,29511 claims
AbbVieSynthroid$325$2,87540 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,724 internal medicine providers in Virginia.

Other internal medicine in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →